Congenital hypopituitarism: When should transcription factor gene screenings be performed?;Hypopituitarisme congénital: Quand analyser les gènes de facteurs de transcription?

Presse Medicale

Volumn 33, Issue 6, 2004, Pages 400-405

  Reynaud, Rachel ^a,b   Barlier, Anne ^a,c   Chadli Chaieb, Molka ^d   Saveanu, Alexandre ^a,b   Simonin, Gilbert ^b   Enjalbert, Alain ^a,c   Brue, Thierry ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADORELIN RECEPTOR; TRANSCRIPTION FACTOR;

CLINICAL EXAMINATION; DIAGNOSTIC VALUE; FOLLOW UP; GENE ISOLATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPOPITUITARISM; MEDICAL DECISION MAKING; PATHOPHYSIOLOGY; REVIEW;

EID: 1942539170     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98607-1     Document Type: Review

References (31)

1. Dasen JS, O'Connell SM, Flynn SE et al. Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 1999; 97: 587-98.
2. Procter AM, Phillips JA 3rd, Cooper DN. The molecular genetics of growth hormone deficiency. Hum Genet 1998; 103: 255-72.
3. Argente J, Perez-Jurado LA, Sotos J.F. Molecular bases of human growth. J Endocr Genet 2000; 1: 179-210.
4. Oliveira HA, Salvatori R, Krauss MP, Oliveira CR, Silva PR, Aguiar-Oliveira MH. Magnetic resonance imaging study of pituitary morphology in subjects homozygous and heterozygous for a null mutation of the GHRH receptor gene. EurJ Endocrinol 2003; 148: 427-32.
5. Ryther RC, McGuinness LM, Phillips JA 3rd, et al. Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II. Hum Genet 2003; 113: 140-8.
6. Binder G, Nagel BH, Ranke MB, Mullis PE. Isolated GH deficiency (IGHD) type II: imaging of the pituitary gland by magnetic resonance reveals characteristic differences in comparison with severe IGHD of unknown origin. Eur J Endocrinol 2002; 147: 755-60.
7. Pulichino AM, Vallette-Kasic S, Couture C et al. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003; 17: 711-16.
8. Pulichino AM, Vallette-Kasic S, Tsai JP, Couture C, Gauthier Y, Drouin J. Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 2003; 17: 738-47.
9. Krude H, Biebermann H, Luck W et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19: 155-7
10. Massin N, Pecheux C, Eloit C et al. X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene J Clin Endocrinot Metab 2003; 88: 2003-8
11. Dode C, Levilliers J, Dupont JM, De Paepe A. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003; 33: 463-5.
12. de Roux N, Young J, Misrahi M et al E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 1997; 337: 1597-602
13. De Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003; 100: 10972-6
14. Li S, Crenshaw EB, 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990; 347: 528-33.
15. Cohen LE, Radovick S. Other transcription factors and hypopituitarism. Rev Endocr Metab Disord 2002; 3: 301-11.
16. Malvagia S, Poggi GM, Pasquini E et al. The de Novo Q167K mutation in the POU1F1 gene leads to combined pituitary hormone deficiency in an Italian patient. Pediatr Res 2003; 54: 635-40
17. Somson MW, Wu W, Dasen JS et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996; 384: 327-33.
18. Wu W, Cogan JD, Pfaffle RW et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18: 147-9.
19. Cogan JD, Wu W, Phillips JA 3rd et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 3346-9.
20. Fluck C, Deladoey J, Rutishauser K et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg->Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998; 83: 3727-34.
21. Vallette-Kasic S, Badier A, Teinturier C et al. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001; 86: 4529-35.
22. Fofanova O, Takamura N, Kinoshita E et al. MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. AJR Am J Roentgenol 2000; 174: 555-9.
23. Teinturier C, Vallette S, Adamsbaum C et al. Pseudotumor of the pituitary due to PROP-1 deletion. J Pediatr Endocrinol Metab 2002; 15: 95-101
24. Netchine I, Sobrier ML, Krude H et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000; 25: 182-6.
25. Sheng HZ, Zhadanov AB, Mosinger B, Jr et al. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996; 272: 1004-7.
26. Sloop KW, Parker GE, Hanna KR, Wright HA, Rhodes SJ. LHX3 transcription factor mutations associated with combined pituitary hormone deficiency impair the activation of pituitary target genes. Gene 2001; 265: 61-9.
27. Raetzman LT, Ward R, Camper SA. Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 2002; 129: 4229-39.
28. Machinis K, Pantel J, Netchine I et aI. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001; 69: 961-8.
29. Dattani MT, Martinez-Barbera JP, Thomas PO et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998; 19: 125-33.
30. Dattani MT, Robinson IC. HESX1 and Septo-Optic Dysplasia. Rev Endocr Metab Disord 2002; 3: 289-300.
31. Amendt BA, Semina EV, Alward WL. Rieger syndrome: a clinical, molecular, and biochemical analysis. Cell Mol Life Sci 2000; 57: 1652-66.